phosphatidylcholines has been researched along with Ovarian Neoplasms in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (8.82) | 18.7374 |
1990's | 3 (8.82) | 18.2507 |
2000's | 13 (38.24) | 29.6817 |
2010's | 13 (38.24) | 24.3611 |
2020's | 2 (5.88) | 2.80 |
Authors | Studies |
---|---|
Gao, S; Gong, TT; Huo, YL; Kang, Y; Li, YZ; Liu, FH; Wu, QJ; Yan, S; Yang, HJ | 1 |
Avila-Pacheco, J; Clish, CB; Eliassen, AH; Kraft, P; Tworoger, SS; Zeleznik, OA | 1 |
Khemapech, N; Lertkhachonsuk, R; Oranratanaphan, S; Termrungruanglert, W; Vasurattana, A | 1 |
Bagnoli, M; Canevari, S; Iorio, E; Pisanu, ME; Podo, F; Ricci, A | 1 |
Almeida, MI; Bottsford-Miller, J; Calin, GA; Han, HD; Ivan, C; Jennings, NB; Jung, EJ; Lopez-Berestein, G; Lu, C; Matsuo, K; Nicoloso, MS; Nishimura, M; Pecot, CV; Rodriguez-Aguayo, C; Rossi, S; Shah, MY; Shahzad, MM; Shimizu, M; Sood, AK; Spizzo, R; Wu, SY; Zand, B; Zhang, X | 1 |
Armaiz-Pena, GN; Bar-Eli, M; Calin, GA; Gharpure, KM; Huang, L; Ivan, C; Lopez-Berestein, G; Mangala, LS; McGuire, M; Nagaraja, AS; Pecot, CV; Pradeep, S; Previs, RA; Rodriguez-Aguayo, C; Rupaimoole, R; Sood, AK; Wu, SY; Yang, D; Zhang, W | 1 |
Ali-Fehmi, R; Armaiz-Pena, GN; Baggerly, KA; Bar-Eli, M; Cooper, LJ; Ehsanipour, EA; Filant, J; Gharpure, KM; Haemmerle, M; Han, HD; Hatakeyama, H; Herbrich, SM; Huang, L; Hung, MC; Ivan, C; Kim, JH; Lee, JS; Lopez-Berestein, G; Maiti, SN; McGuire, MH; Nagaraja, AS; Olsen, C; Pecot, CV; Pham, E; Pradeep, S; Ram, PT; Rodriguez-Aguayo, C; Rupaimoole, R; Seviour, EG; Shen, F; Sood, AK; Tucker, S; Vidal-Anaya, V; Wu, SY; Yang, D; Zhang, M; Zhang, X | 1 |
Bottsford-Miller, JN; Dial, EJ; Dorniak, PL; Fang, D; Filant, J; Haemmerle, M; Hansen, JM; Hatakeyama, H; Hu, W; Huang, Y; Lichtenberger, LM; Lyons, Y; Pradeep, S; Previs, RA; Shen, F; Sood, AK; Taylor, M; Wagner, MJ | 1 |
Brown, R; Dória, ML; Ghaem-Maghami, S; Golf, O; McKenzie, JS; Mroz, A; Phelps, DL; Rosini, F; Speller, A; Strittmatter, N; Takats, Z; Veselkov, K | 1 |
Chen, CA; Hsiao, SM; Hsieh, CY; Lin, HH; Wei, LH | 1 |
Han, HD; Lopez-Berestein, G; Mangala, LS; Sood, AK | 1 |
Bagnoli, M; Bhujwalla, ZM; Canevari, S; Castellano, G; Di Vito, M; Glunde, K; Iorio, E; Mezzanzanica, D; Pisanu, ME; Podo, F; Ricci, A; Venturini, E | 1 |
Bhavane, R; Chiappini, C; Fakhoury, JR; Ferrari, M; Godin, B; Gu, J; Han, HD; Liu, X; Lopez-Berestein, G; Lu, C; Mangala, LS; Mann, AP; Matsuo, K; Mora, E; Nick, AM; Nieves-Alicea, R; Shahzad, MM; Sood, AK; Stone, RL; Tanaka, T; Vivas-Mejia, PE | 1 |
Babu, CR; Chakravarty, D; Curiel, TJ; Dandamudi, R; Lopez-Berestein, G; Roy, SS; Sood, AK; Vadlamudi, RK; Vivas-Mejia, P | 1 |
Armaiz-Pena, G; Baggerly, KA; Bottsford-Miller, J; Coleman, RL; Deavers, MT; Graybill, WS; Kim, HS; Kim, SM; Landen, CN; Lee, JS; Lopez-Berestein, G; Nick, AM; Ozpolat, B; Ram, PT; Sood, AK; Stone, RL; Tekedereli, I; Villares, G; Vivas-Mejia, P | 1 |
Han, SY; Kang, S; Kim, HK; Kim, KP; Kim, YH; Lee, A; Lee, SC; Park, SY; Park, YS; Yoo, CW | 1 |
Cao, R; Chen, J; Dou, A; Lu, X; Wang, Y; Xu, C; Xu, G; Zhao, S | 1 |
Hong, J; Im, KS; Jung, JH; Lee, CO; Lee, DS; Mansoor, TA; Zhao, Q | 1 |
DEALVAREZ, RR; GOODELL, BW | 1 |
Apollonio, P; Bombardelli, E; Ferlini, C; Gallo, D; Giacomelli, S; Morazzoni, P; Prislei, S; Raspaglio, G; Riva, A; Scambia, G | 1 |
Bast, A; Boven, E; den Hartog, GJ; Haenen, GR; van der Vijgh, WJ | 1 |
Allen, C; Blicker, M; Grant, J; Piquette-Miller, M | 1 |
Bucana, C; Chavez-Reyes, A; Deavers, MT; Landen, CN; Lopez-Berestein, G; Schmandt, R; Sood, AK | 1 |
Alberti, P; Canevari, S; D'Ascenzo, S; Dolo, V; Iorio, E; Mezzanzanica, D; Millimaggi, D; Pavan, A; Podo, F; Ramoni, C; Spadaro, F | 1 |
Chavez-Reyes, A; Cole, SW; Coleman, RL; Gershenson, DM; Halder, J; Han, LY; Jennings, NB; Kamat, AA; Landen, CN; Lin, YG; Lopez-Berestein, G; Lutgendorf, SK; Merritt, WM; Schmandt, R; Sood, AK | 1 |
Bucana, C; Coleman, RL; Gershenson, DM; Han, LY; Kamat, AA; Landen, CN; Lin, YG; Lopez-Berestein, G; Lu, C; Mangala, LS; Merritt, WM; Sanguino, AM; Schmandt, R; Sood, AK | 1 |
Allen, C; De Souza, R; Grant, J; Piquette-Miller, M; Vassileva, V | 1 |
De Alvarez, RR; Goodell, BW; Zighelboim, I | 1 |
Algeri, M; D'Incalci, M; Damia, G; Diomede, L; Imperatori, L; Modest, EJ; Salmona, M | 1 |
Crommelin, DJ; Hendriks, JJ; Steerenberg, PA; Storm, G; Vingerhoeds, MH | 1 |
Gaudette, DC; Holub, BJ; Mills, GB; Okita, M | 1 |
Ahl, P; Cabral-Lilly, D; Godin, N; Janoff, A; Meers, P; Purandare, U; Shangguan, T | 1 |
Apollonio, P; Bombardelli, E; Distefano, M; Ferlini, C; Gallo, D; Giacomelli, S; Mancuso, S; Morazzoni, P; Riva, A; Scambia, G | 1 |
Bouchama, S; Henrion, R; Michel, G | 1 |
1 trial(s) available for phosphatidylcholines and Ovarian Neoplasms
Article | Year |
---|---|
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Phosphatidylcholines; Polyethylene Glycols | 2009 |
33 other study(ies) available for phosphatidylcholines and Ovarian Neoplasms
Article | Year |
---|---|
Relationship between different forms of dietary choline and ovarian cancer survival: findings from the ovarian cancer follow-up study, a prospective cohort study.
Topics: Adolescent; Adult; Aged; Choline; Diet; Female; Follow-Up Studies; Humans; Middle Aged; Ovarian Neoplasms; Phosphatidylcholines; Prospective Studies; Receptors, Estrogen; Risk Factors; WT1 Proteins; Young Adult | 2022 |
Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study.
Topics: Adult; Biomarkers, Tumor; Carcinoma, Endometrioid; Case-Control Studies; Ceramides; Cohort Studies; Cystadenocarcinoma, Serous; Female; Humans; Lysophosphatidylcholines; Menopause; Metabolomics; Middle Aged; Ovarian Neoplasms; Phosphatidylcholines; Prospective Studies; Risk; Sphingomyelins | 2020 |
Salvage chemotherapy in recurrent platinum-resistant or refractory epithelial ovarian cancer with Carboplatin and distearoylphosphatidylcholine pegylated liposomal Doxorubicin (lipo-dox®).
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Serous; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Phosphatidylcholines; Polyethylene Glycols; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate | 2013 |
Choline metabolic profiling by magnetic resonance spectroscopy.
Topics: Cell Line, Tumor; Choline; Female; Humans; Magnetic Resonance Spectroscopy; Metabolic Networks and Pathways; Metabolome; Ovarian Neoplasms; Phosphatidylcholines | 2013 |
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cohort Studies; Drug Therapy, Combination; Female; Gene Silencing; Humans; Mice; Mice, Nude; MicroRNAs; Molecular Targeted Therapy; Ovarian Neoplasms; Phosphatidylcholines; Receptor, EphA2; Receptor, EphB2; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2013 |
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; DEAD-box RNA Helicases; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Liposomes; Mice; MicroRNAs; Neoplasms; Ovarian Neoplasms; Phosphatidylcholines; Ribonuclease III; Vascular Endothelial Growth Factor A | 2016 |
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer.
Topics: Animals; Cell Line, Tumor; Down-Regulation; Early Growth Response Protein 1; Female; Gene Regulatory Networks; Genetic Therapy; Homeodomain Proteins; Humans; Kidney Neoplasms; Mice; MicroRNAs; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; Tumor Burden | 2016 |
Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Aspirin; Biomarkers; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Hypoxia; Mice; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; Thromboxanes; Xenograft Model Antitumor Assays | 2016 |
Epithelial ovarian carcinoma diagnosis by desorption electrospray ionization mass spectrometry imaging.
Topics: Adenocarcinoma, Clear Cell; Carcinoma, Endometrioid; Discriminant Analysis; Female; Humans; Immunohistochemistry; Ovarian Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phosphatidylserines; Principal Component Analysis; Spectrometry, Mass, Electrospray Ionization | 2016 |
Liposomal siRNA for ovarian cancer.
Topics: Animals; Carcinoma; Female; Fluorescent Dyes; Gene Silencing; Genetic Therapy; Humans; Liposomes; Mice; Mice, Nude; Ovarian Neoplasms; Phosphatidylcholines; Receptor, EphA2; RNA, Small Interfering | 2009 |
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
Topics: Choline Kinase; Enzyme Activation; Epithelial Cells; Female; Humans; Membrane Transport Proteins; Ovarian Neoplasms; Phosphatidylcholines; Phospholipase D; Phosphoric Diester Hydrolases; Type C Phospholipases | 2010 |
Sustained small interfering RNA delivery by mesoporous silicon particles.
Topics: Animals; Cell Line, Tumor; Female; Gene Silencing; Genetic Therapy; Humans; Liposomes; Mice; Mice, Nude; Nanoparticles; Ovarian Neoplasms; Phosphatidylcholines; Receptor, EphA2; RNA, Small Interfering; Silicon; Xenograft Model Antitumor Assays | 2010 |
Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Co-Repressor Proteins; Cytoskeleton; Female; Gene Expression Profiling; Humans; Liposomes; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Nude; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Phosphatidylcholines; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Transcription Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |
Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Carcinoma; Cell Survival; Crk-Associated Substrate Protein; Disease-Free Survival; Docetaxel; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Female; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Gene Silencing; Green Fluorescent Proteins; Humans; Immunoblotting; Immunohistochemistry; Kaplan-Meier Estimate; Membrane Proteins; Mice; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Middle Aged; Multivariate Analysis; Ovarian Neoplasms; Phosphatidylcholines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction; Taxoids; Transfection; Transplantation, Heterologous; Up-Regulation | 2011 |
Alteration in lipid and protein profiles of ovarian cancer: similarity to breast cancer.
Topics: Breast Neoplasms; Carcinoma, Ovarian Epithelial; Epithelial Cells; Female; Humans; Lipid Metabolism; Lipids; Neoplasm Proteins; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphatidylcholines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2011 |
[Study of phospholipid profile of ovarian tumor by high performance liquid chromatography-mass spectrometry].
Topics: Chromatography, High Pressure Liquid; Female; Humans; Lysophosphatidylcholines; Metabolome; Ovarian Neoplasms; Phosphatidylcholines; Phospholipids; Spectrometry, Mass, Electrospray Ionization | 2011 |
New lysophosphatidylcholines and monoglycerides from the marine sponge Stelletta sp.
Topics: Animals; Antineoplastic Agents; Artemia; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Glycerides; Humans; Korea; Lung Neoplasms; Lysophosphatidylcholines; Molecular Structure; Ovarian Neoplasms; Phosphatidylcholines; Porifera | 2003 |
SERUM LIPID PARTITIONS AND FATTY ACID COMPOSITION (USING GAS CHROMATOGRAPHY) IN GYNECOLOGICAL CANCER.
Topics: Adenocarcinoma; Biomedical Research; Cholesterol; Choriocarcinoma; Chromatography; Chromatography, Gas; Endometriosis; Fatty Acids; Female; Genital Neoplasms, Female; Glycerides; Humans; Lecithins; Lipids; Lipoproteins; Lysophosphatidylcholines; Neoplasm Metastasis; Ovarian Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Pregnancy; Sphingomyelins; Uterine Cervical Neoplasms | 1964 |
Antitumour activity of the silybin-phosphatidylcholine complex, IdB 1016, against human ovarian cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; DNA, Complementary; Drug Evaluation; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; Silymarin; Vascular Endothelial Growth Factor A | 2003 |
Lecithinized copper,zinc-superoxide dismutase as a protector against doxorubicin-induced cardiotoxicity in mice.
Topics: Animals; Breast Neoplasms; Cell Division; Cell Line, Tumor; Doxorubicin; Female; Growth Inhibitors; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Myocardium; Ovarian Neoplasms; Phosphatidylcholines; Superoxide Dismutase | 2004 |
Hybrid films from blends of chitosan and egg phosphatidylcholine for localized delivery of paclitaxel.
Topics: Adsorption; Algorithms; Animals; Cell Line, Tumor; Cell Survival; Chitosan; CHO Cells; Cricetinae; Eggs; Excipients; Female; Humans; Lipids; Microspheres; Ovarian Neoplasms; Paclitaxel; Phosphatidylcholines; Spectroscopy, Fourier Transform Infrared | 2005 |
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.
Topics: Animals; Cell Line, Tumor; Down-Regulation; Female; Genetic Therapy; Humans; Liposomes; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; Receptor, EphA2; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2005 |
Alterations of choline phospholipid metabolism in ovarian tumor progression.
Topics: Carbon Radioisotopes; Cell Line, Tumor; Choline; Choline Kinase; Disease Progression; Female; Humans; Nuclear Magnetic Resonance, Biomolecular; Ovarian Neoplasms; Phosphatidylcholines; Phospholipase D; Phosphorylcholine; Type C Phospholipases | 2005 |
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.
Topics: Animals; Apoptosis; Cell Proliferation; Down-Regulation; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Liposomes; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2006 |
Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer.
Topics: Animals; Cell Line, Tumor; Female; Genetic Therapy; Humans; Liposomes; Mice; Mice, Nude; Ovarian Neoplasms; Phosphatidylcholines; RNA, Small Interfering; Transplantation, Heterologous | 2006 |
Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biocompatible Materials; Chitosan; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Implants; Eggs; Female; Glycerol; Humans; Injections, Intraperitoneal; Mice; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Phosphatidylcholines; Xenograft Model Antitumor Assays | 2007 |
Fatty acid composition of serum lipids in pregnancy and gynecologic cancer.
Topics: Adenocarcinoma; Cholesterol; Choriocarcinoma; Chromatography, Gas; Chromatography, Thin Layer; Fatty Acids; Fatty Acids, Nonesterified; Female; Glycerides; Humans; Lipids; Ovarian Neoplasms; Palmitic Acids; Phosphatidylcholines; Phosphatidylethanolamines; Pregnancy; Sphingomyelins; Triglycerides; Uterine Cervical Neoplasms | 1967 |
In vivo anti-tumor activity of synthetic ether lipids is not enhanced by pharmacological modulation of tumor lipid composition.
Topics: Animals; Antineoplastic Agents; Cell Membrane; Cholesterol; Drug Combinations; Female; Glycerides; Leukemia L1210; Lymphoma, Large B-Cell, Diffuse; Male; Membrane Fluidity; Membrane Lipids; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Ovarian Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipid Ethers; Phospholipids; Viscosity | 1994 |
Targeted delivery of diphtheria toxin via immunoliposomes: efficient antitumor activity in the presence of inactivating anti-diphtheria toxin antibodies.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Cell Division; Cell Line; Cholesterol; Diphtheria Toxin; Dose-Response Relationship, Drug; Drug Carriers; Female; Humans; Immunoglobulin Fab Fragments; Liposomes; Mice; Ovarian Neoplasms; Phosphatidylcholines | 1996 |
Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients.
Topics: Adult; Aged; Fatty Acids; Female; Humans; Leukemia; Lysophosphatidylcholines; Middle Aged; Ovarian Neoplasms; Phosphatidylcholines | 1997 |
A novel N-acyl phosphatidylethanolamine-containing delivery vehicle for spermine-condensed plasmid DNA.
Topics: Animals; Artificial Gene Fusion; Female; Freeze Fracturing; Genetic Therapy; Genetic Vectors; Humans; Liposomes; Mice; Microscopy, Electron; Microscopy, Fluorescence; Ovarian Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Spermine; Transfection; Tumor Cells, Cultured | 2000 |
Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatin.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Mice; Mice, Nude; Neoplasms, Experimental; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; Silymarin; Tumor Cells, Cultured | 2002 |
[Surgical importance of evaluation of fetal pulmonary maturity by examination of the amniotic fluid].
Topics: Adult; Amniotic Fluid; Cesarean Section; Chromatography; Embryonic and Fetal Development; Female; Humans; Hysterectomy; Lung; Ovarian Neoplasms; Phosphatidylcholines; Phospholipids; Pregnancy; Pregnancy Complications; Preoperative Care; Time Factors | 1973 |